Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
- DOI
- 10.1016/j.lungcan.2025.108798
- Published
- 2025 Nov
- Container
- Lung cancer (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2025.108798,
title = {Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.},
author = {Brandão M and Prisciandaro E and Xenophontos E and Mariolo A and Sadeghi AH and Filippi AR and Levy A and Bandura A and Caramella C and Dickhoff C and de Margerie-Mellon C and Faivre-Finn C and Portik D and Sanchez-Lorente D and De Ruysscher D and Smit E and Gobbini E and Fadel E and Ruffini E and Olmetto E and Cortiula F and Bahce I and Houda I and Opitz I and Naidoo J and Edwards J and Remon J and Benitez JC and Trujillo JC and Derks J and Amrane K and Hartemink KJ and Stathopoulos K and Hendriks LEL and Iglesias M and Occhipinti M and Guckenberger M and Giaj Levra N and Girard N and Reguart N and Mercier O and Bironzo P and Hofman P and Petersen RH and De Angelis R and Abgral R and Terrisse S and Popat S and Pierret T and Blum TG and Ricardi U and Dionisi V and Berghmans T and Dingemans AC and European Organisation for Research, Treatment of Cancer EORTC Lung Cancer Group},
year = {2025},
journal = {Lung cancer (Amsterdam, Netherlands)},
doi = {10.1016/j.lungcan.2025.108798},
url = {https://doi.org/10.1016/j.lungcan.2025.108798}
}RIS
TY - JOUR TI - Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group. AU - Brandão M AU - Prisciandaro E AU - Xenophontos E AU - Mariolo A AU - Sadeghi AH AU - Filippi AR AU - Levy A AU - Bandura A AU - Caramella C AU - Dickhoff C AU - de Margerie-Mellon C AU - Faivre-Finn C AU - Portik D AU - Sanchez-Lorente D AU - De Ruysscher D AU - Smit E AU - Gobbini E AU - Fadel E AU - Ruffini E AU - Olmetto E AU - Cortiula F AU - Bahce I AU - Houda I AU - Opitz I AU - Naidoo J AU - Edwards J AU - Remon J AU - Benitez JC AU - Trujillo JC AU - Derks J AU - Amrane K AU - Hartemink KJ AU - Stathopoulos K AU - Hendriks LEL AU - Iglesias M AU - Occhipinti M AU - Guckenberger M AU - Giaj Levra N AU - Girard N AU - Reguart N AU - Mercier O AU - Bironzo P AU - Hofman P AU - Petersen RH AU - De Angelis R AU - Abgral R AU - Terrisse S AU - Popat S AU - Pierret T AU - Blum TG AU - Ricardi U AU - Dionisi V AU - Berghmans T AU - Dingemans AC AU - European Organisation for Research, Treatment of Cancer EORTC Lung Cancer Group PY - 2025 JO - Lung cancer (Amsterdam, Netherlands) DO - 10.1016/j.lungcan.2025.108798 UR - https://doi.org/10.1016/j.lungcan.2025.108798 ER -
APA
M, B., E, P., E, X., A, M., AH, S., AR, F., A, L., A, B., C, C., C, D., C, D. M., C, F., D, P., D, S., D, D. R., E, S., E, G., E, F., E, R., E, O., F, C., I, B., I, H., I, O., J, N., J, E., J, R., JC, B., JC, T., J, D., K, A., KJ, H., K, S., LEL, H., M, I., M, O., M, G., N, G. L., N, G., N, R., O, M., P, B., P, H., RH, P., R, D. A., R, A., S, T., S, P., T, P., TG, B., U, R., V, D., T, B., AC, D., & Group, E. O. F. R. T. O. C. E. L. C. (2025). Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2025.108798
Source records
- pubmed · retrieved 2026-09-25T11:32:29.725Z
- europe-pmc · retrieved 2026-09-25T11:32:29.736Z
- hal · retrieved 2026-09-25T11:32:29.785Z